Weight loss as a predictor of mortality in patients with interstitial lung disease

The interstitial lung diseases (ILDs) are a diverse group of diffuse parenchymal lung disorders that commonly result in pulmonary fibrosis. ILDs are broadly classified according to known and unknown aetiologies. Connective tissue disease-associated ILD (CTD-ILD) and chronic hypersensitivity pneumonitis (CHP) are among the most common ILDs of known aetiology, while idiopathic pulmonary fibrosis (IPF) and unclassifiable ILD (U-ILD) are among the most common of unknown aetiology [1–4]. Weight loss in patients with ILD was associated with increased mortality risk in those with IPF and U-ILD http://ow.ly/Nk0D30l2Apm

[1]  Lilian T. Kuranishi,et al.  Change in FVC and survival in chronic fibrotic hypersensitivity pneumonitis , 2017, Thorax.

[2]  Y. Obase,et al.  Risk factors for an acute exacerbation of idiopathic pulmonary fibrosis , 2016, Respiratory Research.

[3]  Joyce S Lee,et al.  Predicting survival across chronic interstitial lung disease: the ILD-GAP model. , 2014, Chest.

[4]  Meilan K. Han,et al.  Predicting pulmonary fibrosis disease course from past trends in pulmonary function. , 2014, Chest.

[5]  H. Collard,et al.  Prevalence and prognosis of unclassifiable interstitial lung disease , 2012, European Respiratory Journal.

[6]  A. Fischer,et al.  Interstitial lung disease in connective tissue disorders , 2012, The Lancet.

[7]  M. Selman,et al.  Hypersensitivity pneumonitis: insights in diagnosis and pathobiology. , 2012, American journal of respiratory and critical care medicine.

[8]  Joyce S Lee,et al.  A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis , 2012, Annals of Internal Medicine.

[9]  Takeshi Johkoh,et al.  American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management , 2011 .

[10]  A. Nicholson,et al.  Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis , 2009, European Respiratory Journal.

[11]  M. Collazo-Clavell,et al.  Body mass index and mortality in patients with idiopathic pulmonary fibrosis. , 2007, Chest.

[12]  G. Zou,et al.  A modified poisson regression approach to prospective studies with binary data. , 2004, American journal of epidemiology.

[13]  Abdissa Negassa,et al.  Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study , 2003, The Lancet.

[14]  J. Vestbo,et al.  Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study , 2002, European Respiratory Journal.

[15]  J. Vestbo,et al.  Prognostic value of nutritional status in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.